Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net earnings (loss)	$ 60.2	$ (193.5)
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:
Depreciation and amortization	830.7	1,001.9
Share-based Compensation	34.7	34.8
Deferred income tax benefit	(119.7)	(57.8)
Loss from equity method investments	34.5	33.2
Other non-cash items	97.4	63.5
Litigation settlements and other contingencies, net	26.6	24.4
Changes in operating assets and liabilities:
Accounts receivable	122.6	198.9
Inventories	(275.8)	(326.8)
Accounts payable	(234.5)	(71.6)
Income taxes	49.3	(94.8)
Other operating assets and liabilities, net	44.6	17.0
Net cash provided by operating activities	670.6	629.2
Cash flows from investing activities:
Cash paid for acquisitions, net	0.0	(7.1)
Capital expenditures	(87.9)	(97.2)
Purchase of available for sale securities and other investments	(90.2)	(12.7)
Proceeds from the sale of marketable securities	33.1	12.5
Payments for product rights and other, net	(76.4)	(129.5)
Proceeds from the sale of assets	1.3	0.0
Net cash used in investing activities	(220.1)	(234.0)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	33.2	5.5
Payments of long-term debt	(589.0)	(555.5)
Change in short-term borrowings, net	0.0	24.3
Taxes paid related to net share settlement of equity awards	(7.1)	(8.3)
Contingent consideration payments	(43.6)	(38.8)
Payments of financing fees	(1.2)	(2.1)
Proceeds from exercise of stock options	0.6	4.0
Other items, net	(2.0)	(1.0)
Net cash used in financing activities	(609.1)	(571.9)
Effect on cash of changes in exchange rates	(7.8)	0.1
Net decrease in cash, cash equivalents and restricted cash	(166.4)	(176.6)
Cash, cash equivalents and restricted cash — beginning of period	491.1	389.3
Cash, cash equivalents and restricted cash — end of period	$ 324.7	$ 212.7